Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00534781 · ClinicalTrials.gov registry record · Phase 4
Achilles Tendinosis Study; Comparison of Radiofrequency to Surgical MicroDebridement
A Phase 4 study of Achilles Pain and Achilles Tendinosis, sponsored by ArthroCare Corporation.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
- 2
- Study locations
NCT00534781: Completed Phase 4 study of Achilles Pain and Achilles Tendinosis, sponsored by ArthroCare Corporation.
NCT00534781 is a Phase 4 study of Achilles Pain and Achilles Tendinosis that has completed, run by ArthroCare Corporation. The registered enrollment target is 60 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00534781, a Phase 4 study of Achilles Pain and Achilles Tendinosis, has completed, sponsored by ArthroCare Corporation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a research study to evaluate the outcomes after the study procedure for pain and discomfort in the heel caused from an injury in the Achilles tendon which is located on the back of the foot (commonly called "Achilles tendinitis"-Achilles tendinosis) that has not gotten better with medicine and/or other therapy. Researchers want to see if using the study device changes outcomes for 1 year after the study procedure.
Conditions Studied
Interventions
- DEVICE plasma microdebrider
- PROCEDURE Mechanical Surgical Debridement
Study Locations (2)
Maryland
- Greater Chesapeake Orthopaedic Associates - Baltimore
Ohio
- Orthopaedic Foot and Ankle Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2007-09 |
| Est. Completion | 2010-09 |
| Phase | Phase 4 |
What the finished NCT00534781 record still lists
NCT00534781 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower).
The record links to 3 conditions, with Achilles Pain appearing as the primary indexed condition, and to 2 interventions - of which plasma microdebrider is the first listed.
NCT00534781 reports a single indexed study location in Maryland, Ohio.
Frequently Asked Questions
What is clinical trial NCT00534781 about?
NCT00534781 is a clinical study titled "Achilles Tendinosis Study; Comparison of Radiofrequency to Surgical MicroDebridement". This is a research study to evaluate the outcomes after the study procedure for pain and discomfort in the heel caused from an injury in the Achilles tendon which is located on the back of the foot (commonly called "Achilles tendinitis"-Achilles tendinosis) that has not gotten better with medicine a...
What is the current status of trial NCT00534781?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2007-09. Estimated completion is 2010-09.
What conditions does trial NCT00534781 study?
This clinical trial studies the following conditions: Achilles Pain, Achilles Tendinosis, Heel Pain.
What interventions are being tested in trial NCT00534781?
The interventions under investigation include: plasma microdebrider (DEVICE), Mechanical Surgical Debridement (PROCEDURE).
Who is sponsoring clinical trial NCT00534781?
This trial is sponsored by ArthroCare Corporation, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00534781 being conducted?
This trial has 2 study locations across Maryland, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00534781's enrollment target sits among peer trials
60 1125th of 2000 higher than 799 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia